Literature DB >> 34697131

Screening Tools for Sarcopenia.

Hiroki Nishikawa1,2, Akira Asai3, Shinya Fukunishi3,2, Toshihisa Takeuchi3, Masahiro Goto3, Takeshi Ogura3, Shiro Nakamura3, Kazuki Kakimoto3, Takako Miyazaki3,2, Shuhei Nishiguchi4, Kazuhide Higuchi3.   

Abstract

The elderly people are characterized by multiple comorbidities, dementia, and are at risk of developing sarcopenia and frailty. Sarcopenia is defined by loss of muscle mass and muscle strength or physical decline. Sarcopenia is a main component of physical frailty. Screening tools for sarcopenia that can be easily determined in daily practice are useful and include the SARC-F screening tool. SARC-F is a questionnaire consisting of five questions: Strength (S), Assistance walking (A), Rising from a chair (R), Climbing stairs (C), and Falls (F) on a scale of 0 to 2. The recommended cutoff value is ≥4 points. The SARC-F has been shown to correlate well with clinical outcomes in the elderly and various underlying diseases, while it is also true that the SARC-F has its shortcomings such as low sensitivity for sarcopenia. In this review, we mainly outline the SARC-F and mention other screening tools for sarcopenia.
Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  SARC-F; Sarcopenia; review; screening tool; sensitivity; specificity

Mesh:

Year:  2021        PMID: 34697131      PMCID: PMC8627754          DOI: 10.21873/invivo.12595

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  66 in total

1.  Cancer-related fatigue and biochemical parameters among cancer patients with different stages of sarcopenia.

Authors:  Bangyan Wang; Sudip Thapa; Ting Zhou; Huiquan Liu; Lu Li; Guang Peng; Shiying Yu
Journal:  Support Care Cancer       Date:  2019-05-17       Impact factor: 3.603

2.  Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria.

Authors:  Hiroki Nishikawa; Makoto Shiraki; Akira Hiramatsu; Kyoji Moriya; Keisuke Hino; Shuhei Nishiguchi
Journal:  Hepatol Res       Date:  2016-09       Impact factor: 4.288

3.  Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment.

Authors:  Liang-Kung Chen; Jean Woo; Prasert Assantachai; Tung-Wai Auyeung; Ming-Yueh Chou; Katsuya Iijima; Hak Chul Jang; Lin Kang; Miji Kim; Sunyoung Kim; Taro Kojima; Masafumi Kuzuya; Jenny S W Lee; Sang Yoon Lee; Wei-Ju Lee; Yunhwan Lee; Chih-Kuang Liang; Jae-Young Lim; Wee Shiong Lim; Li-Ning Peng; Ken Sugimoto; Tomoki Tanaka; Chang Won Won; Minoru Yamada; Teimei Zhang; Masahiro Akishita; Hidenori Arai
Journal:  J Am Med Dir Assoc       Date:  2020-02-04       Impact factor: 4.669

4.  Calf circumference as a surrogate marker of muscle mass for diagnosing sarcopenia in Japanese men and women.

Authors:  Ryoko Kawakami; Haruka Murakami; Kiyoshi Sanada; Noriko Tanaka; Susumu S Sawada; Izumi Tabata; Mitsuru Higuchi; Motohiko Miyachi
Journal:  Geriatr Gerontol Int       Date:  2014-09-20       Impact factor: 2.730

5.  Designing pharmaceutical trials for sarcopenia in frail older adults: EU/US Task Force recommendations.

Authors:  B Vellas; M Pahor; T Manini; D Rooks; J M Guralnik; J Morley; S Studenski; W Evans; C Asbrand; R Fariello; S Pereira; Y Rolland; G Abellan van Kan; M Cesari; Wm C Chumlea; R Fielding
Journal:  J Nutr Health Aging       Date:  2013-07       Impact factor: 4.075

6.  Sarcopenia, dynapenia, and body composition in Parkinson's disease: are they good predictors of disability?: a case-control study.

Authors:  Firuzan Fırat Ozer; Sibel Akın; Murat Gultekin; Gozde Erturk Zararsız
Journal:  Neurol Sci       Date:  2019-10-03       Impact factor: 3.307

7.  Relationship between sarcopenia and depression in older patients with diabetes: An investigation using the Japanese version of SARC-F.

Authors:  Satoshi Ida; Kazuya Murata; Mari Nakai; Sho Ito; Theodore K Malmstrom; Yuki Ishihara; Kanako Imataka; Akihiro Uchida; Kou Monguchi; Ryutaro Kaneko; Ryoko Fujiwara; Hiroka Takahashi
Journal:  Geriatr Gerontol Int       Date:  2018-07-18       Impact factor: 2.730

Review 8.  Reliability and Concurrent Validity of the SARC-F and Its Modified Versions: A Systematic Review and Meta-Analysis.

Authors:  Stefanie N Voelker; Nikolaos Michalopoulos; Andrea B Maier; Esmee M Reijnierse
Journal:  J Am Med Dir Assoc       Date:  2021-06-15       Impact factor: 4.669

9.  Easy surveillance of muscle volume decline in chronic liver disease patients using finger-circle (yubi-wakka) test.

Authors:  Atsushi Hiraoka; Hirofumi Izumoto; Hidetaro Ueki; Takeaki Yoshino; Toshihiko Aibiki; Tomonari Okudaira; Hiroka Yamago; Yoshifumi Suga; Ryuichiro Iwasaki; Hideomi Tomida; Kenichiro Mori; Hideki Miyata; Eiji Tsubouchi; Masato Kishida; Tomoyuki Ninomiya; Masashi Hirooka; Masanori Abe; Bunzo Matsuura; Yoichi Hiasa; Kojiro Michitaka
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-02-21       Impact factor: 12.910

10.  Effect of dysphagia rehabilitation in patients receiving enteral nutrition at home nursing care: a retrospective cohort study.

Authors:  Hiroyasu Furuya; Takeshi Kikutani; Kumi Igarashi; Keiichiro Sagawa; Yuri Yajima; Reiko Machida; Takashi Tohara; Noriaki Takahashi; Fumiyo Tamura
Journal:  J Oral Rehabil       Date:  2020-06-07       Impact factor: 3.837

View more
  2 in total

1.  Sarcopenia screening in elderly with Alzheimer's disease: performances of the SARC-F-3 and MSRA-5 questionnaires.

Authors:  Marco Filardi; Giancarlo Logroscino; Giulia Bramato; Roberta Barone; Maria Rosaria Barulli; Chiara Zecca; Rosanna Tortelli
Journal:  BMC Geriatr       Date:  2022-09-17       Impact factor: 4.070

Review 2.  Dietary Recommendations for Post-COVID-19 Syndrome.

Authors:  Luigi Barrea; William B Grant; Evelyn Frias-Toral; Claudia Vetrani; Ludovica Verde; Giulia de Alteriis; Annamaria Docimo; Silvia Savastano; Annamaria Colao; Giovanna Muscogiuri
Journal:  Nutrients       Date:  2022-03-20       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.